Copyright
©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1562-1575
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1562
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1562
Figure 1 Receiver operating characteristic curve of the studied miRNAs.
Figure 2 Survival curve among the studied parameters.
A: Survival curve in relation to stage; B: Survival curve in relation to response to treatment according to mRECIST; C: Survival curve in relation to miRNA-326.
- Citation: Youssef SS, Elfiky A, Nabeel MM, Shousha HI, Elbaz T, Omran D, Marie MS, Elzahry MA, Abul-Fotouh A, Hashem A, Guda MF, Abdelaziz AO. Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians. World J Hepatol 2022; 14(8): 1562-1575
- URL: https://www.wjgnet.com/1948-5182/full/v14/i8/1562.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i8.1562